Prognostic Value and Biological Significance of GUCY1A2 in Gastric Cancer: A Bioinformatics Analysis Base on TCGA Database
Table 2.
Association of clinical characteristics and survival by univariate coxregression and Multivariate analysis.
| Characteristic | HR(95%CI) | p-value | | a. Univariate cox regression | | Age | 1.03(1.01-1.05) | 0.004* | | Gender | 1.50(0.98-2.30) | 0.062 | | Grade | 1.25(0.85-1.84) | 0.252 | | Clinical stage | 1.51(1.20-1.91) | 0.001* | | T stage | 1.28(1.00-1.63) | 0.050 | | M stage | 2.07(1.07-3.98) | 0.030* | | N stage | 1.54(0.97-2.45) | 0.070 | | GUCY1A2 | 1.44(1.03-2.02) | 0.034* | | b. Multivariate analysis | | Age | 1.05(1.02-1.07) | 0.000* | | Gender | 1.57(1.01-2.44) | 0.045* | | Grade | 1.33(0.89-1.99) | 0.167 | | Clinical stage | 1.71(1.09-2.69) | 0.019* | | T stage | 1.03(0.73-1.45) | 0.086 | | M stage | 1.83(0.80-4.16) | 0.150* | | N stage | 0.69(0.34-1.38) | 0.292 | | GUCY1A2 | 1.76(1.20-2.56) | 0.004* | HR: Hazard Ratio, CI: confident interval; *, p<0.05
|
HR: Hazard Ratio, CI: confident interval; *, p<0.05 |